AYA Cancer SurvivorsNCT05562570
Exercise and Pain in AYACS
A study testing Physical activity intervention coupled with standard post-cancer directed treatment care in people with AYA Cancer Survivors, run by Milton S. Hershey Medical Center at 1 site in United States.
Trial summary
The purpose of this study is to demonstrate that integration of exercise intervention into standard post-cancer directed treatment care will improve patient reported pain, decrease the need for medications to manage chronic pain and improve functional and psychosocial outcomes in survivors of cancers in adolescents… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- AYA Cancer Survivors
- What is being tested?
- Physical activity intervention coupled with standard post-cancer directed treatment care
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited States
- Study dates
- 10 Oct 2022to 1 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Male and female AYA cancer survivors diagnosed with any type of cancer between the ages of 15 and 39 years old
- AYA cancer survivors who have completed all standard/planned cancer treatment and are stable at the time of recruitment
- AYA cancer survivors are < 1-year post cancer therapy
- AYA cancer survivors who have chronic pain (pain will be self-reported by the participant, will have to be ≥1 on a scale of 10 and lasting for 3 months or longer)
- AYA cancer survivors who are age ≥18 years old at the time of enrollment
- AYA cancer survivors who are and who are not non-ambulatory/wheelchair bound.
Show all 11Show fewer
- AYA cancer survivors must be able to speak, read and understand the English language
- AYA cancer survivors must be able to provide and understand informed consent
- AYA cancer survivors must be able to attend three visits (baseline, 8 and 16-week follow-up) at the Penn State Health Milton S. Hershey Medical Center
- AYA cancer survivors must have access to a computer with wifi, smartphone with wifi or tablet with wifi
- Note: The agreement of the attending oncologist will be required for the participation of AYA cancer survivors eligible for this study.
Who cannot join
- AYA cancer survivors who have not completed all standard/planned cancer treatment and/or not in complete remission at the time of recruitment
- AYA cancer survivors who are > 1-year post cancer therapy
- AYA cancer survivors who are < 18 years old at the time of enrollment
- cancer survivors who have evidence of an absolute contraindication to complete any of the physical assessments in their medical record. This exclusion criterion is at the oncologist's discretion when research staff will contact the medical oncologist via secure email or secure message through the electronic medical record for approval to approach their patients for the study and for medical clearance. The oncologists can update this information at any time during the study if there is evidence of an absolute contraindication to complete any of the physical assessments.
- AYA cancer survivors who have history of refractory or recurrent cancer
- AYA cancer survivors who are unable to speak, read, and understand the English language
Trial locations and contacts
1 site in 1 country.
United States1 site
Penn State Health Children's Hospital
Hershey, Pennsylvania, 17033
About this study
Official title: Exercise Intervention Coupled With Standard Post-cancer Directed Treatment Care to Reduce Chronic Pain in Adolescents and Young Adult Cancer Survivors Who Have Completed Cancer-directed Therapy Less Than One Year
The purpose of this study is to demonstrate that integration of exercise intervention into standard post-cancer directed treatment care will improve patient reported pain, decrease the need for medications to manage chronic pain and improve functional and psychosocial outcomes in survivors of cancers in adolescents and young adults (AYA). Our central hypothesis is that integration of exercise interventions into standard post-cancer directed treatment care will be acceptable and feasible while improving patients' pain, decreasing the cumulative dose of pain medication and improving patients' functional and psychosocial outcomes as compared to patients who only receive standard post-cancer directed treatment care.
- Conditions
- AYA Cancer Survivors
- Being tested
- Physical activity intervention coupled with standard post-cancer directed treatment care, Standard post-cancer directed treatment care control
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Physical activity intervention coupled with standard post-cancer directed treatment careBehavioural
AYACS will participate in a 16-week physical activity program. AYACS will be instructed to start with a session duration of <15-min, three days per week at low intensity (e.g., activities expending >1.5 to 3 METs or intensity <5 on a scale of 0 to 10). Any type of physical activity will be acceptable. The program will be individualized, and activity increased according to patients' health status, results from the physical function assessment, and most recent week's achieved physical activities. The program will include support calls and texts from research staff (exercise physiologist). The program will be modified and adapted during support calls or texts, including frequency, intensity, time and type to maximize AYACS' success. AYACS will receive a Fitbit at the beginning of the intervention.
Standard post-cancer directed treatment care controlOther
AYACS in the control group will not participate in a 16-week physical activity program and will not receive support calls or texts. Physical activity advice according to the Exercise Guidelines for Cancer Survivors will be offered to AYACS following completion of 16-week follow-up. Moreover, AYACS will receive a Fitbit following completion of 16-week follow-up
| Study group | Role | What they receive |
|---|---|---|
| Physical activity intervention coupled with standard post-cancer directed treatment care group | Experimental | Not described Receives: Behavioral: Physical activity intervention coupled with standard post-cancer directed treatment care |
| Standard post-cancer directed treatment care control group | Other | Not described Receives: Other: Standard post-cancer directed treatment care control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptability of the intervention
The number of participants approached who agree to participate in the study
Measured: Baseline
Feasibility of the intervention
The number of participants randomized to the physical activity program intervention coupled with standard post-cancer directed treatment care who complete at least 50% of the physical activity intervention
Measured: Baseline to week 16
Secondary outcomes (9)
Measure changes in chronic pain levels
Self-reported chronic pain questionnaire using the Brief Pain Inventory Range 0 to 10, Higher scores indicate more pain and greater interference
Measured: Baseline, week 8 and week 16
Measure changes in cumulative dose of pain medications
Chart review: number of pain medications prescribed, total dosage and length of time prescribed.
Self-reported pain medication: usage of prescription medication and information about the use of non-prescription pain medications (e.g., over the counter oral and topical pain medications).
The Prescription Drug Monitoring Program will be accessed to gather information on all filled prescriptions for controlled substances within the state of Pennsylvania.
Morphine equivalent dose will be calculated for each patient after looking at the total daily amount of each opioid the patient is taking. Using the standard conversion factors developed by the CDC, the Morphine milligram equivalent equates the many different opioids into a standard value that is based on morphine and its potency providing an easily interpretable metric for representing opioid utilization
Measured: Baseline, week 4, week 8, week 12 and week 16
Measure changes in patient reported outcomes
Psychosocial questionnaires using the NIH developed PROMIS questionnaires, including self-reported physical function mobility, anxiety, depressive symptoms, fatigue, social isolation, pain interference, pain intensity, sleep disturbance, sleep-related impairment and cognitive function PROMIS questionnaires assessing patient-reported outcomes on 5-point Likert scale (min value: 1 to max value: 5) responses
Measured: Baseline, week 8 and week 16
Measure changes in physical activity level (Godin-Shephard leisure-time physical activity questionnaire)
Self-reported physical activity questionnaire using the Godin-Shephard leisure-time physical activity questionnaire.
- Less than 14 units: Insufficiently active
- 14 to 23 units: Moderately active
- 24 units or more: Active
Measured: Baseline, week 8 and week 16
Measure changes in physical activity level (International Physical Activity Questionnaire-Short Form)
Self-reported physical activity questionnaire using the International Physical Activity Questionnaire-Short Form
- Self-reports physical activity frequency
- Self-reports physical activity intensity
- Self-reports physical activity time
- Self-reports physical activity type
Measured: Baseline, week 8 and week 16
Measure changes in patient functional outcomes (6-min walking test)
Validated physical function tests, including the 6-min walking test Further distances indicate greater physical function
Measured: Baseline and week 16
Measure changes in patient functional outcomes (30-second chair stand test)
Validated physical function tests, including the 30-second chair stand test Greater amounts of sit/stands indicate greater physical function
Measured: Baseline and week 16
Measure changes in patient functional outcomes ("Timed Up and Go" test)
Validated physical function tests, including the "Timed Up and Go" test Shorter durations indicate greater physical function
Measured: Baseline and week 16
Measure changes in patient functional outcomes (grip strength test)
Validated physical function tests, including the grip strength test Greater grip strength indicate greater physical function
Measured: Baseline and week 16
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Oct 2022
- Study start10 Oct 2022
- Primary completion1 May 2025
- Study completion1 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AYA Cancer SurvivorsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized controlled trial
- Masking
- None (open label)
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Milton S. Hershey Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Smita Dandekar, Penn State Health Milton S Hershey Medical Center
- Investigators
- Smita Dandekar, MD, Principal investigator, Penn State College of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05562570
- Sponsor's protocol ID
- STUDY00020904
- Status last verified
- May 2025
- First submitted
- 26 Sep 2022
- Last updated
- 14 May 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Exercise Intervention Coupled With Standard Post-cancer Directed Treatment Care to Reduce Chronic Pain in Adolescents and Young Adult Cancer Survivors Who Have Completed Cancer-directed Therapy Less Than One Year
- ClinicalTrials.gov ID
- NCT05562570
- Acronym / sponsor ID
- STUDY00020904
- Conditions
- AYA Cancer Survivors
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Milton S. Hershey Medical CenterUniversity, hospital or other
- Study start
- 10 Oct 2022 (actual)
- Primary completion
- 1 May 2025 (actual)
- Study completion
- 1 May 2025 (actual)
- First posted
- 3 Oct 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to demonstrate that integration of exercise intervention into standard post-cancer directed treatment care will improve patient reported pain, decrease the need for medications to manage chronic pain and improve functional and psychosocial outcomes in survivors of cancers in adolescents and young adults (AYA). Our central hypothesis is that integration of exercise interventions into standard post-cancer directed treatment care will be acceptable and feasible while improving patients' pain, decreasing the cumulative dose of pain medication and improving patients' functional and psychosocial outcomes as compared to patients who only receive standard post-cancer directed treatment care.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Randomized controlled trial
| Arm | Type | Receives |
|---|---|---|
| Physical activity intervention coupled with standard post-cancer directed treatment care group | Experimental | Behavioral: Physical activity intervention coupled with standard post-cancer directed treatment care |
| Standard post-cancer directed treatment care control group | Other | Other: Standard post-cancer directed treatment care control |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (11 listed)
- Male and female AYA cancer survivors diagnosed with any type of cancer between the ages of 15 and 39 years old
- AYA cancer survivors who have completed all standard/planned cancer treatment and are stable at the time of recruitment
- AYA cancer survivors are < 1-year post cancer therapy
- AYA cancer survivors who have chronic pain (pain will be self-reported by the participant, will have to be ≥1 on a scale of 10 and lasting for 3 months or longer)
- AYA cancer survivors who are age ≥18 years old at the time of enrollment
Key exclusion criteria (6 listed)
- AYA cancer survivors who have not completed all standard/planned cancer treatment and/or not in complete remission at the time of recruitment
- AYA cancer survivors who are > 1-year post cancer therapy
- AYA cancer survivors who are < 18 years old at the time of enrollment
- cancer survivors who have evidence of an absolute contraindication to complete any of the physical assessments in their medical record. This exclusion criterion is at the oncologist's discretion when research staff will contact the medical oncologist via secure email or secure message through the electronic medical record for approval to approach their patients for the study and for medical clearance. The oncologists can update this information at any time during the study if there is evidence of an absolute contraindication to complete any of the physical assessments.
- AYA cancer survivors who have history of refractory or recurrent cancer
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Physical activity intervention coupled with standard post-cancer directed treatment careAYACS will participate in a 16-week physical activity program. AYACS will be instructed to start with a session duration of <15-min, three days per week at low intensity (e.g., activities expending >1.5 to 3 METs or intensity <5 on a scale of 0 to 10). Any type of physical activity will be acceptable. The program will be individualized, and activity increased according to patients' health status, results from the physical function assessment, and most recent week's achieved physical activities. The program will include support calls and texts from research staff (exercise physiologist). The program will be modified and adapted during support calls or texts, including frequency, intensity, time and type to maximize AYACS' success. AYACS will receive a Fitbit at the beginning of the intervention. | Behavioural | Physical activity intervention coupled with standard post-cancer directed treatment care group |
| Standard post-cancer directed treatment care controlAYACS in the control group will not participate in a 16-week physical activity program and will not receive support calls or texts. Physical activity advice according to the Exercise Guidelines for Cancer Survivors will be offered to AYACS following completion of 16-week follow-up. Moreover, AYACS will receive a Fitbit following completion of 16-week follow-up | Other | Standard post-cancer directed treatment care control group |
Primary outcome
Acceptability of the intervention
Time frame: Baseline
The number of participants approached who agree to participate in the study
Feasibility of the intervention
Time frame: Baseline to week 16
The number of participants randomized to the physical activity program intervention coupled with standard post-cancer directed treatment care who complete at least 50% of the physical activity intervention
9 secondary outcomes
Measure changes in chronic pain levels
Time frame: Baseline, week 8 and week 16
Measure changes in cumulative dose of pain medications
Time frame: Baseline, week 4, week 8, week 12 and week 16
Measure changes in patient reported outcomes
Time frame: Baseline, week 8 and week 16
Measure changes in physical activity level (Godin-Shephard leisure-time physical activity questionnaire)
Time frame: Baseline, week 8 and week 16
Measure changes in physical activity level (International Physical Activity Questionnaire-Short Form)
Time frame: Baseline, week 8 and week 16
Measure changes in patient functional outcomes (6-min walking test)
Time frame: Baseline and week 16
Measure changes in patient functional outcomes (30-second chair stand test)
Time frame: Baseline and week 16
Measure changes in patient functional outcomes ("Timed Up and Go" test)
Time frame: Baseline and week 16
Measure changes in patient functional outcomes (grip strength test)
Time frame: Baseline and week 16
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 May 2025.
Related trials for AYA Cancer Survivors
RecruitingPhase 2
PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study
Sarcoma,Soft Tissue
Not yet recruiting
Food Is Medicine In Survivorship (Foodiis-AYA): Examining The Feasibility And Acceptability Of A Remotely-Delivered Meal Kit And Culinary Medicine Program For Survivors Of Adolescent/Young Adult (AYA) Cancer
Survivorship, Meal Kit
Not yet recruiting
AYA Cancer Transitions Program
Cancer, Cancer Survivorship
Active, not recruiting
mHealth Physical Activity Intervention for Young Cancer Survivors
Cancer
Active, not recruitingObservational study
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Acute Lymphoblastic Leukemia, Hodgkin Lymphoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Smita Dandekar, MD principal investigator
Penn State College of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Physical activity intervention coupled with standard post-cancer directed treatment care in people with AYA Cancer Survivors, run by Milton S. Hershey Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 11 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptability of the intervention (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2025.